MicroRNA‐210 repression facilitates advanced glycation end‐product (AGE)‐induced cardiac mitochondrial dysfunction and apoptosis via JNK activation

Abstract Hyperglycemia results in the formation of reactive oxygen species which in turn causes advanced glycation end products (AGEs) formation, leading to diabetic cardiomyopathy. Our previous study showed that AGE‐induced reactive oxygen species‐dependent apoptosis is mediated via protein kinase C delta (PKCδ)‐enhanced mitochondrial damage in cardiomyocytes. By using microRNA (miRNA) database, miRNA‐210 was predicted to target c‐Jun N‐terminal kinase (JNK), which were previously identified as downstream of PKCδ in regulating mitochondrial function. Therefore, we hypothesized that miR‐210 mediates PKCδ‐dependent upregulation of JNK to cause cardiac mitochondrial damage and apoptosis following AGE exposure. AGE‐exposed cells showed activated cardiac JNK, PKCδ, and apoptosis, which were reversed by treatment with a JNK inhibitor and PKCδ‐KD (deficient kinase). Cardiac miR‐210 and mitochondrial function were downregulated following AGE exposure. Furthermore, JNK was upregulated and involved in AGE‐induced mitochondrial damage. Interestingly, luciferase activity of the miR‐210 mimic plus JNK WT‐3′‐untranslated region overexpressed group was significantly lower than that of miR‐210 mimic plus JNK MT‐3′UTR group, indicating that JNK is a target of miR‐210. Moreover, JNK activation induced by AGEs was reduced by treatment with the miR‐210 mimic and reversed by treatment with the miR‐210 inhibitor, indicating the regulatory function of miR‐210 in JNK activation following AGE exposure. Additionally, JNK‐dependent mitochondrial dysfunction and apoptosis were reversed following treatment with the miR‐210 mimic, while the miR‐210 inhibitor showed no effect on JNK‐induced mitochondrial dysfunction and apoptosis in AGE‐exposed cardiac cells. Taken together, our study showed that PKCδ‐enhanced JNK‐dependent mitochondrial damage is mediated through the reduction of miR‐210 in cardiomyocytes following AGE exposure.